TCTC Holdings’s Covetrus, Inc. Common Stock CVET Stock Holding History

TCTC Holdings’s Portfolio CVET Stock Details CVET Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-300	Closed	-$7K	–	415
2020 Q3	$7K	Hold	300	–	–	﹤0.01%	350
2020 Q2	$5K	Buy	+300	New	+$3.94K	﹤0.01%	355

Other funds holding CVET

CDR

Clayton Dubilier & Rice New York $895M AUM 792.56% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

SCHF (GPE) Wilson, Wyoming $781M AUM 24.06% 1-Year Est. Return

FCM

Freshford Capital Management Rye Brook, New York $200M AUM 31.49% 1-Year Est. Return

TCTC Holdings's CVET Position: Q4 2020 in Review

TCTC Holdings sold out of Covetrus, Inc. Common Stock (CVET) in Q4 2020, closing a stake of 300 shares — an estimated $7K sold.

TCTC Holdings first reported a position in CVET in Q2 2020 and held it in 2 quarters. The position peaked at $7K in Q3 2020. 277 funds tracked by Wall St. Rank hold CVET as of Q4 2020.

TCTC Holdings reported no remaining Covetrus, Inc. Common Stock position as of Q4 2020 after selling out during the quarter.
TCTC Holdings sold 300 Covetrus, Inc. Common Stock shares in Q4 2020, an estimated $7K.
TCTC Holdings first reported a position in Covetrus, Inc. Common Stock in Q2 2020 and held it in 2 quarters.
TCTC Holdings's Covetrus, Inc. Common Stock position peaked at $7K in Q3 2020.
277 funds tracked by Wall St. Rank held Covetrus, Inc. Common Stock as of Q4 2020.

Based on TCTC Holdings's 13F filing for Q4 2020, filed 10 Feb 2021.